Ligand validation:4BVA

NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE

NDP is a Ligand Of Interest in 4BVA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BVA_NDP_B_1313	92%	13%	0.079	0.97	2.04	1.93	13	11	1	0	100%	1
4BVA_NDP_A_1313	71%	13%	0.127	0.947	2.01	1.96	13	9	2	0	100%	1
4BV9_NDP_B_1312	72%	9%	0.129	0.953	2.15	2.31	15	12	2	0	100%	1
1US0_NDP_A_318	100%	45%	0.027	0.998	1.21	0.91	3	-	4	0	100%	1
2I16_NDP_A_319	100%	46%	0.028	0.998	1.2	0.9	3	1	0	0	100%	1
2I17_NDP_A_319	100%	46%	0.029	0.998	1.22	0.89	3	-	0	0	100%	1
2PF8_NDP_A_318	100%	46%	0.031	0.998	1.17	0.93	3	-	4	0	100%	1
2PFH_NDP_A_318	100%	26%	0.03	0.998	1.79	1.2	8	7	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.